−541KRW
−53.46 BKRW
96.45 M
About NEOIMMUNETECH
Sector
Industry
CEO
Luke Oh
Website
Headquarters
Rockville
Employees (FY)
100
Founded
2014
ISIN
KR8840140006
FIGI
BBG00YT9C180
NeoImmuneTech, Inc. is a clinical-stage biopharmaceutical company. which engages in the development of T cell-centered novel immunotherapeutics. The firm develops its product NT-I7 for the treatment of lymphopenia. The company was founded by Se Hwan Yang in January 2014 and is headquartered in Rockville, MD.
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.
